Local Anesthetic

Brachial Plexus Block Group 1 for Postoperative Pain

Phase 4

Recruiting

Research Sponsored by Benaroya Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Surgical candidate for Arthroscopic rotator cuff surgery

ASA I-III

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up60 minutes after surgery

Awards & highlights

Drug Has Already Been Approved

No Placebo-Only Group

Pivotal Trial

Study Summary

This trial looks at a new way to do nerve block procedures, considering both the success and side effects of the block.

Eligible Conditions

Postoperative Pain

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 minutes after surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 minutes after surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Block Success

Lung Function

Secondary outcome measures

Diaphragm Excursion

Pulse Oximetry

Side Effects

+1 more

Awards & Highlights

Drug Has Already Been Approved

The FDA has already approved this drug, and is just seeking more data.

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Pivotal Trial

The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Brachial Plexus Group 3Experimental Treatment1 Intervention

Suprascapular

Group II: Brachial Plexus Group 2Experimental Treatment1 Intervention

Supraclavicular

Group III: Brachial Plexus Block Group 1Experimental Treatment1 Intervention

Interscalene

0 / 4Eligibility criteria met

Find a site

Who is running the clinical trial?

Benaroya Research InstituteLead Sponsor

43 Previous Clinical Trials

9,364 Total Patients Enrolled

1 Trials studying Postoperative Pain

124 Patients Enrolled for Postoperative Pain

Media Library

Ropivacaine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT05868993 — Phase 4

Postoperative Pain Research Study Groups: Brachial Plexus Block Group 1, Brachial Plexus Group 2, Brachial Plexus Group 3

Postoperative Pain Clinical Trial 2023: Ropivacaine Highlights & Side Effects. Trial Name: NCT05868993 — Phase 4

Ropivacaine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868993 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current regulatory status of Brachial Plexus Block Group 1?

"Given the Phase 4 trial status, our experts at Power assigned Brachial Plexus Block Group 1 a rating of 3 to reflect its established safety profile."

Answered by AI

Is there availability for participation in this experiment?

"As evidenced by the information on clinicaltrials.gov, this research study is actively seeking qualified participants. The original posting was made on February 17th 2023 and most recently updated on May 11th 2023."

Answered by AI

What is the cohort size for this experimental protocol?

"Affirmative. According to the available information on clinicaltrials.gov, this research is currently recruiting participants with an initial posting date of February 17th 2023 and a most recent edit on May 11th 2023. The study requires 150 people from 1 medical site."

Answered by AI

What end-results is this research attempting to realize?

"This 60-minute study looks to assess Lung Function, as well as gauge Vital Capacity (in L), Pulse Oximetry changes, and the rate of Dyspnea/Horner's/Hoarseness side effects."

Answered by AI